Evergreening the World’s Most Profitable Medicine

Door 2 juli 2019 English, Farma, Featured

Even after the expiration of Humira’s patent protection, pharmaceutical company AbbVie almost completely fended off biosimilar competition for this blockbuster medicine in the Netherlands. ‘Their behaviour defies any description.’ By Lucien Hordijk. Read article.